Literature DB >> 35693130

Profiling Carbohydrate Metabolism in Liver and Hepatocellular Carcinoma with [13C]-Glycerate Probes.

Jun Chen1, Evan LaGue2, Junjie Li1, Chendong Yang3, Edward P Hackett1, Manuel Mendoza2, Jeffry R Alger1, Ralph J DeBerardinis3, Ian R Corbin1, Kelvin L Billingsley2, Jae Mo Park1.   

Abstract

The interplay between glycolysis and gluconeogenesis is central to carbohydrate metabolism. Here, we describe novel methods to assess carbohydrate metabolism using [13C]-probes derived from glycerate, a molecule whose metabolic fate in mammals remains underexplored. Isotope-based studies were conducted via NMR and mass spectrometry analyses of freeze-clamped liver tissue extracts after [2,3-13C2]glycerate infusion. The ex vivo investigations were correlated with in vivo measurements using hyperpolarized [1-13C]glycerate. Application of [13C]glycerate to N-nitrosodiethylamine (DEN)-treated rats provided further assessments of intermediary carbohydrate metabolism in hepatocellular carcinoma. This method afforded direct analyses of control versus DEN tissues, and altered ratios of 13C metabolic products as well as unique glycolysis intermediates were observed in the DEN liver/tumor. Isotopomer studies showed increased glycerate uptake and altered carbohydrate metabolism in the DEN rats.

Entities:  

Keywords:  NMR spectroscopy; glycerate; hepatocellular carcinoma; hyperpolarized 13C; metabolism

Year:  2021        PMID: 35693130      PMCID: PMC9187054          DOI: 10.1002/anse.202100034

Source DB:  PubMed          Journal:  Anal Sens        ISSN: 2629-2742


  40 in total

1.  Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo.

Authors:  Jae Mo Park; Marvin Wu; Keshav Datta; Shie-Chau Liu; Andrew Castillo; Heather Lough; Daniel M Spielman; Kelvin L Billingsley
Journal:  J Am Chem Soc       Date:  2017-05-08       Impact factor: 15.419

2.  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305.

Authors:  Enrique Chávez; María Guadalupe Lozano-Rosas; Mariana Domínguez-López; Gabriela Velasco-Loyden; Jesús Rafael Rodríguez-Aguilera; Concepción José-Nuñez; Marietta Tuena de Gómez-Puyou; Victoria Chagoya de Sánchez
Journal:  J Pharmacol Exp Ther       Date:  2017-02-16       Impact factor: 4.030

3.  Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.

Authors:  Yong-Fang Ding; Zhen-Hui Wu; Ying-Jie Wei; Luan Shu; Yun-Ru Peng
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-25       Impact factor: 4.553

4.  PASADENA hyperpolarized 13C phospholactate.

Authors:  Roman V Shchepin; Aaron M Coffey; Kevin W Waddell; Eduard Y Chekmenev
Journal:  J Am Chem Soc       Date:  2012-02-28       Impact factor: 15.419

Review 5.  Pathogenesis of type 2 diabetes mellitus.

Authors:  Ralph A DeFronzo
Journal:  Med Clin North Am       Date:  2004-07       Impact factor: 5.456

6.  Active pyruvate dehydrogenase and impaired gluconeogenesis in orthotopic hepatomas of rats.

Authors:  Min Hee Lee; Ralph J DeBerardinis; Xiaodong Wen; Ian R Corbin; A Dean Sherry; Craig R Malloy; Eunsook S Jin
Journal:  Metabolism       Date:  2019-10-28       Impact factor: 8.694

7.  Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate.

Authors:  Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Peder E Z Larson; Andrea L Harzstark; Marcus Ferrone; Mark van Criekinge; Jose W Chang; Robert Bok; Ilwoo Park; Galen Reed; Lucas Carvajal; Eric J Small; Pamela Munster; Vivian K Weinberg; Jan Henrik Ardenkjaer-Larsen; Albert P Chen; Ralph E Hurd; Liv-Ingrid Odegardstuen; Fraser J Robb; James Tropp; Jonathan A Murray
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

8.  Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose.

Authors:  Tiago B Rodrigues; Eva M Serrao; Brett W C Kennedy; De-En Hu; Mikko I Kettunen; Kevin M Brindle
Journal:  Nat Med       Date:  2013-12-08       Impact factor: 53.440

9.  High PKM2 expression is independently correlated with decreased overall survival in hepatocellular carcinoma.

Authors:  Dong-Hui Lu; Wen-Wen Lv; Wen-Xing Li; Yue-Dong Gao
Journal:  Oncol Lett       Date:  2018-07-06       Impact factor: 2.967

Review 10.  Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinoma.

Authors:  Shanmugasundaram Ganapathy-Kanniappan; Rani Kunjithapatham; Jean-Francois Geschwind
Journal:  Oncotarget       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.